Qilu Pharmaceutical Research Center

Qilu Pharmaceutical Group is a large comprehensive modern pharmaceutical enterprise in China, specializing in the research, development, production, and sales of pharmaceutical preparations and APIs for the treatment of tumors, cardiovascular and cerebrovascular diseases, anti-infectives, psychiatric disorders, neurological diseases, and ophthalmic diseases. The Group is headquartered in Jinan City, Shandong Province, with eleven major production bases nationwide, five global R&D centers, and 12 subsidiaries, forming a complete industrial value chain covering drug R&D, API synthesis, preparation processing, product packaging, and market sales. R&D investment is at the forefront of the industry, with over 300 products on the market, and many products, preparations, and raw materials are exported to more than 100 countries and regions worldwide.
Qilu Pharmaceutical Innovative Drug R&D Center is a comprehensive platform for Qilu's innovative drug research, talent cultivation, and international cooperation and exchange. It is responsible for the overall planning of Qilu's innovative drug R&D, the development of innovative drug projects, and coordination with overseas innovative drug R&D companies (R&D centers in Seattle, San Francisco, and Boston, USA).
"To become a world-class pharmaceutical enterprise with global influence" is the great vision of Qilu Pharmaceutical Group. The Group will base itself in China, lay out globally, gather talents, continuously enhance innovation and internationalization capabilities, and focus on introducing and cultivating outstanding innovative talents. Qilu sincerely invites outstanding talents from home and abroad to join us!